Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis

As a staple chemotherapy medicine, cisplatin (DDP) is extensively applied in cancer patients, but its drug resistance is limited. Numerous studies have elucidated that long non-coding RNA (lncRNA) performs as a pivotal agent in osteosarcoma (OS). Nevertheless, lncRNA long intergenic non-coding 00641...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, JinShan, Zhu, ZiQiang, Dong, Suwei, Wang, YunQing, Wang, JianQang, Chen, HongLiang, Duan, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208475/
https://www.ncbi.nlm.nih.gov/pubmed/35266447
http://dx.doi.org/10.1080/21655979.2022.2045090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208475/
https://www.ncbi.nlm.nih.gov/pubmed/35266447
http://dx.doi.org/10.1080/21655979.2022.2045090

Ejemplares similares